A large Phyllodes tumor following fennel consumption: Report of a rare case

Document Type : Case report

Authors

1 Instructor, Department of Anesthesiology, Clinical Research Development Unit of Peymanieh Hospital, Faculty of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran.

2 B.Sc. in Health, Women’s Health and Diseases Research Center, Faculty of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran.

3 Assistant Professor, Department of Surgery, Women’s Health and Diseases Research Center, Faculty of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran.

Abstract

Introduction: Phyllodes (PTs) tumors are fibroblastic neoplasms of the breast. PTs are relatively rare and include less than 1% of all breast neoplasms. In this study, a case of large tumor of Phyllodes following fennel consumption was reported.
Case presentation: The patient was a 47-year-old MCzabz female who complained of a large mass in the left breast and referred to Peymaniyeh Hospital in Jahrom. The patient had a history of infertility for 8 years. She had a 3 cm mass in the left breast from the past 2 years. During previous 7 months, she has used fennel for 3 months due to menstrual irregularities.
Conclusion: It seems that the increasing of the breast tumor size in this patient is due to arbitrary consumption of fennel; because fennel has a lot of estrogen, which affects Endoplasmic Reticulum, and tumor filament cells also have beta ER-estrogen receptors; in this patient, the arbitrary consumption of fennel for 3 months has led to the sudden increase in the volume of this mass in the breast.

Keywords


  1. Tan PH, Jayabaskar T, Chuah KL, Lee HY, Tan Y, Hilmy M, et al. Phyllodes tumors of the breast: the role of pathologic parameters. American Journal of Clinical Pathology 2005; 123(4):529-40.
  2. Kleer CG, Giordano TJ, Braun T, Oberman HA. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast. Modern Pathology 2001; 14(3):185-90.
  3. Dacic S, Kounelis S, Kouri E, Jones MW. Immunohistochemical profile of cystosarcoma phyllodes of the breast: a study of 23 cases. The breast journal 2002; 8(6):376-81.
  4. Niezabitowski A, Lackowska B, Rys J, Kruczak A, Kowalska T, Mitus J, et al. Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases. Breast cancer research and treatment 2001; 65(1):77-85.
  5. Kaya R, Pesterelý HE, Erdogan G, Gülkesen KH, Karavelý S. Proliferating activity in differential diagnosis of benign phyllodes tumor and cellular fibroadenomas: is it helpful?. Pathology Oncology Research 2001; 7(3):213-6.
  6. Moffat CJ, Pinder SE, Dixon AR, Elston CW, Blamey RW, Ellis IO. Phyllodes tumours of the breast: a clinicopathological review of thirty‐two cases. Histopathology 1995; 27(3):205-18.
  7. Ang MK, Ooi AS, Thike AA, Tan P, Zhang Z, Dykema K, et al. Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression. Breast cancer research and treatment 2011; 129(2):319-29.
  8. Tan PH, Thike AA, Tan WJ, Thu MM, Busmanis I, Li H, et al. Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. Journal of clinical pathology 2012; 65(1):69-76.
  9. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, Van de Vijver MJ, et al. Intraductal papillary lesions. WHO classification of tumours of the breast, 4nd ed. IARC Press, Lyon; 2012.
  10. Lenhard MS, Kahlert S, Himsl I, Ditsch N, Untch M, Bauerfeind I. Phyllodes tumour of the breast: clinical follow-up of 33 cases of this rare disease. European Journal of Obstetrics & Gynecology and Reproductive Biology 2008; 138(2):217-21.
  11. Karim RZ, Gerega SK, Yang YH, Spillane A, Carmalt H, Scolyer RA, et al. Phyllodes tumours of the breast: a clinicopathological analysis of 65 cases from a single institution. The Breast 2009; 18(3):165-70.
  12. Umpleby HC, Moore I, Royle GT, Guyer PB, Taylor I. An evaluation of the preoperative diagnosis and management of cystosarcoma phyllodes. Annals of the Royal College of Surgeons of England 1989; 71(5):285-88.
  13. Salvadori B, Cusumano F, Bo RD, Delledonne V, Grassi M, Rovini D, et al. Surgical treatment of phyllodes tumors of the breast. Cancer 1989; 63(12):2532-6.
  14. Treves N. A Study of Cystosarcoma Phyllodes. Ann N Y Acad Sci 1964; 144:922-36.
  15. Agha RA, Borrelli MR, Farwana R, Koshy K, Fowler AJ, Orgill DP, et al. The SCARE 2018 statement: updating consensus Surgical CAse REport (SCARE) guidelines. International Journal of Surgery 2018; 60:132-6.
  16. Thompson LU, Robb P, Serraino M, Cheung F. Mammalian lignan production from various foods. Nutrition and Cancer 1991; 16(1).
  17. Namavar Jahromi B, Tartifizadeh A, Khabnadideh S. Comparison of fennel and mefenamic acid for the treatment of primary dysmenorrhea. International Journal of Gynecology & Obstetrics 2003; 80(2):153-7.
  18. Albert-Puleo M. Fennel and anise as estrogenic agents. Journal of Ethnopharmacology 1980; 2(4):337-44.
  19. Rahimikian F, Rahimi R, Golzareh P, Bekhradi R, Mehran A. Effect of Foeniculum vulgare Mill.(fennel) on menopausal symptoms in postmenopausal women: a randomized, triple-blind, placebo-controlled trial. Menopause 2017; 24(9):1017-21.
  20. Saharkhiz MJ, Tarakeme A. Essential oil content and composition of fennel (Foeniculum vulgare L.) fruits at different stages of development. Journal of Essential Oil Bearing Plants 2011; 14(5):605-9.
  21. Sadeghpour N, Montaseri A, Najafpour A, Dolatkhah H, Rajabzadeh A, Khaki AA. Study of Foeniculum vulgare (Fennel) Seed Extract Effects on Serum Level of Oxidative Stress. Crescent Journal of Medical and Biological Sciences 2015; 2(2): 59-63.
  22. Khazaei M, Montaseri A, Khazaei MR, Khanahmadi M. Study of Foeniculum vulgare effect on folliculogenesis in female mice. International journal of fertility & sterility 2011; 5(3):122-7.
  23. Ostad SN, Soodi M, Shariffzadeh M, Khorshidi N, Marzban H. The effect of fennel essential oil on uterine contraction as a model for dysmenorrhea, pharmacology and toxicology study. Journal of ethnopharmacology 2001; 76(3):299-304.
  24. Gandomani HS. Infertility and Smoking. International Journal of Fertility & Sterility 2013; 7:116.
  25. Mechtersheimer G, Krüger KH, Born IA, Möller P. Antigenic profile of mammary fibroadenoma and cystosarcoma phyllodes: A study using antibodies to estrogen-and progesterone receptors and to a panel of cell surface molecules. Pathology-Research and Practice 1990; 186(4):427-38.
  26. Umekita Y, Yoshida H. Immunohistochemical study of hormone receptor and hormone-regulated protein expression in phyllodes tumour: comparison with fibroadenoma. Virchows Archiv 1998; 433(4):311-4.
  27. Shoker BS, Jarvis C, Clarke RB, Anderson E, Munro C, Davies MP, et al. Abnormal regulation of the oestrogen receptor in benign breast lesions. Journal of clinical pathology 2000; 53(10):778-83.
  28. Tse GM, Lee CS, Kung FY, Scolyer RA, Law BK, Lau TS, et al. Hormonal receptors expression in epithelial cells of mammary phyllodes tumors correlates with pathologic grade of the tumor: a multicenter study of 143 cases. American journal of clinical pathology 2002; 118(4):522-6.
  29. Palmieri C, Saji S, Sakaguchi H, Cheng G, Sunters A, O Hare MJ, et al. The expression of oestrogen receptor (ER)-beta and its variants, but not ERalpha, in adult human mammary fibroblasts. Journal of molecular endocrinology 2004; 33(1):35-50.
  30. Chen CM, Chen CJ, Chang CL, Shyu JS, Hsieh HF, Harn HJ. CD34, CD117, and actin expression in phyllodes tumor of the breast. Journal of Surgical Research 2000; 94(2):84-91.
  31. Burga AM, Tavassoli FA. Periductal stromal tumor: a rare lesion with low-grade sarcomatous behavior. The American journal of surgical pathology 2003; 27(3):343-8.
  32. Garlet BB, Zogbi L, de Lima JP, de Souza Favalli PP, Krahe FD. Recurrent borderline phyllodes tumor of the breast submitted to mastectomy and immediate reconstruction: Case report. International journal of surgery case reports 2019; 60:25-9.
  33. Shimizu T, Ebihara Y, Serizawa H, Toyoda M, Hirota T. Histopathological study of stromal smooth muscle cells in fibroadenoma of the breast. Pathology international 1996; 46(6):442-9.
  34. Trapido EJ, Brinton LA, Schairer C, Hoover R. Estrogen replacement therapy and benign breast disease. Journal of the National Cancer Institute 1984; 73(5):1101-5.
  35. Gori L, Gallo E, Mascherini V, Mugelli A, Vannacci A, Firenzuoli F. Can estragole in fennel seed decoctions really be considered a danger for human health? A fennel safety update. Evidence-Based Complementary and Alternative Medicine 2012; 2012.
  36. Schwartz HJ, Jones RT, Rojas AR, Squillace DL, Yunginger JW. Occupational allergic rhinoconjunctivitis and asthma due to fennel seed. Annals of Allergy, Asthma & Immunology 1997; 78(1):37-40.
  37. Mansourabadi AH, Shams A, Mansouri R, Najafi A, Ajami M. Effects of fennel, asafetida and ginseng ethanolic extracts on growth and proliferation of mouse breast cancer 4T1 cell lines. Advanced Herbal Medicine 2015; 1(2):34-9.